PetVivo Holdings, Inc. (PETV)

Market Cap	28.91M +130.1%
Revenue (ttm)	1.11M +16.3%
Net Income	-10.21M
EPS	-0.38
Shares Out	36.60M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,106
Open	0.7300
Previous Close	0.7800
Day's Range	0.7000 - 0.8030
52-Week Range	0.5995 - 1.6900
Beta	1.28
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 26, 2026

About PetVivo Holdings

PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company’s lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.

• Industry: Medical Devices
• Sector: Healthcare
• CEO: John Lai
• Employees: 24
• Stock Exchange: OTCMKTS
• Ticker Symbol: PETV

Financial Performance

In fiscal year 2025, PetVivo Holdings's revenue was $1.13 million, an increase of 16.91% compared to the previous year's $968,706. Losses were -$8.40 million, -23.33% less than in 2024.